Humacyte Inc (HUMA) (Q3 2026) Earnings Call Highlights: SYMVEST Sales Surge 151% as ATEV ...
Humacyte Inc (HUMA) posted a 151% sequential jump in SYMVEST sales, expanded ordering hospitals to 49, and confirmed plans to file the supplemental BLA for ATEV in dialysis access later this month. Related Stocks: HUMA ,